PapersPMID:16309928
Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- RCT · 50 participants · 3 months
- Dose studied, every finding
- MSM 3 g twice a day (6 g/day total) for 12 weeks
- Population, every finding
- Fifty men and women, 40-76 years of age with knee osteoarthritis pain; WOMAC visual analogue scale format
What moved
How to read these marks →“Compared to placebo, MSM produced significant decreases in WOMAC pain and physical function impairment (P<0.05).”
- Decreases WOMAC physical function subscale
very limited
- Decreases WOMAC pain subscale
very limited
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Fifty men and women, 40-76 years of age with knee OA pain
- Participants
- 50
- Comparator
- placebo
- Duration
- 84 days
- Endpoints measured
- 5